Lifeway Foods/$LWAY

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Lifeway Foods

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.

Ticker

$LWAY
Primary listing

Employees

292

Lifeway Foods Metrics

BasicAdvanced
$385M
35.95
$0.70
0.45
-

What the Analysts think about Lifeway Foods

Analyst ratings (Buy, Hold, Sell) for Lifeway Foods stock.

Bulls say / Bears say

Record Q2 2025 net sales of $53.9 million, an 18% year-on-year increase on a comparable basis, mark Lifeway’s highest quarterly revenue and extend its six-year streak of uninterrupted growth (Nasdaq).
Completion of stage one at the Waukesha facility doubled fermentation tank capacity, positioning Lifeway to double production by Q3 2026 and meet accelerating consumer demand (Nasdaq).
Full-year 2024 net sales reached a record $186.8 million, up 17% year-over-year and marking the 21st consecutive quarter of growth, underscoring Lifeway’s U.S. kefir market leadership and momentum (Nasdaq).
A bitter family feud involving CEO Julie Smolyansky and her ousted mother and brother has sparked proxy battles and legal disputes, posing a significant governance distraction and leadership risk (Barron's).
Shares plunged 21% to $26.58 shortly after Danone withdrew its acquisition interest, highlighting the stock’s vulnerability to M&A-related volatility and investor sentiment shifts (Barron's).
Ongoing legal and governance disputes with both Danone and dissatisfied founding family members could divert management focus and erode strategic execution amid continued litigation and proxy contests (Barron's).
Data summarised monthly by Lightyear AI. Last updated on 2 Nov 2025.

Lifeway Foods Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Lifeway Foods Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $LWAY

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs
Buy Lifeway Foods stock | $LWAY Share Price | Lightyear